MyFinsight
Home
Blog
About
Contact
Download
Download image
Gross profit
$81,583K
(85.97%↑ Y/Y)
Net product revenue
$77,467K
(54.86%↑ Y/Y)
Cost of products sold
-$4,116K
(-166.87%↓ Y/Y)
Cost of products sold
-$4,116K
(-166.87%↓ Y/Y)
Gross profit
$81,583K
(85.97%↑ Y/Y)
Operating income (loss)
$1,937K
(692.35%↑ Y/Y)
Investment and other
income, net
$532K
(-12.79%↓ Y/Y)
Total operating
expense
$79,646K
(80.21%↑ Y/Y)
Income (loss) before
income taxes
$54K
(102.13%↑ Y/Y)
Interest expense
$2,415K
(-14.36%↓ Y/Y)
Selling, general and
administrative expenses
$52,636K
(30.31%↑ Y/Y)
Research and development
expenses
$27,010K
(610.23%↑ Y/Y)
Net income (loss)
$20K
(100.76%↑ Y/Y)
Income tax provision
(benefit)
$34K
(-61.36%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
AVADEL PHARMACEUTICALS PLC (AVDL)
AVADEL PHARMACEUTICALS PLC (AVDL)